About: Final report of a phase II evaluation of paclitaxel in patients with advanced squamous cell carcinoma of the head and neck: an Eastern Cooperative Oncology Group trial (PA390)

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Final report of a phase II evaluation of paclitaxel in patients with advanced squamous cell carcinoma of the head and neck: an Eastern Cooperative Oncology Group trial (PA390) Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 June 1998

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в червні 1998 (uk) im Juni 1998 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xunu de 1998 (ast) scientific article published on 01 June 1998 (en)
publication date	wds:Q74608100-45924A3C-6A50-4618-8686-8A69CA6EEA37
publication date	1998-06-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q74608100-38A28BC5-B6F6-4E4F-BC02-503F4A897090 wds:Q74608100-77569181-1880-4B9A-9F7D-6B5FD319D017 wds:Q74608100-B5F176FA-DC3E-4CDC-B420-8B2B9C4D0F09 wds:Q74608100-BBBA6546-1A95-4DBB-BD11-0D0CDA342DB6 wds:Q74608100-BF75EE9A-F5A9-433F-8F57-AA267E658057 wds:Q74608100-EEF952C4-78A5-4ADF-910A-1CA07675535D
author name string	Adams G Neuberg D DeConti RC Forastiere AA Taylor SG 4th Shank D
rdfs:label	Final report of a phase II evaluation of paclitaxel in patients with advanced squamous cell carcinoma of the head and neck: an Eastern Cooperative Oncology Group trial (nl) Final report of a phase II evaluation of paclitaxel in patients with advanced squamous cell carcinoma of the head and neck: an Eastern Cooperative Oncology Group trial (PA390) (en)
skos:prefLabel	Final report of a phase II evaluation of paclitaxel in patients with advanced squamous cell carcinoma of the head and neck: an Eastern Cooperative Oncology Group trial (nl) Final report of a phase II evaluation of paclitaxel in patients with advanced squamous cell carcinoma of the head and neck: an Eastern Cooperative Oncology Group trial (PA390) (en)
name	Final report of a phase II evaluation of paclitaxel in patients with advanced squamous cell carcinoma of the head and neck: an Eastern Cooperative Oncology Group trial (nl) Final report of a phase II evaluation of paclitaxel in patients with advanced squamous cell carcinoma of the head and neck: an Eastern Cooperative Oncology Group trial (PA390) (en)
title	wds:Q74608100-986F166D-A36C-44D8-BAFD-FEF5AC9C8DE6
title	Final report of a phase II evaluation of paclitaxel in patients with advanced squamous cell carcinoma of the head and neck: an Eastern Cooperative Oncology Group trial (PA390) (en)
page(s)	wds:Q74608100-903B1CAD-13EB-4D7F-A7BA-62433DE6D03C
page(s)	2270-2274
instance of	wds:Q74608100-D18503AF-A217-487B-83E5-BED06CC9F86C
instance of	scholarly article
main subject	wds:Q74608100-5069C9E0-6D1F-44BB-884D-2BCC9E90ECEF wds:Q74608100-77DB1DE5-DEB4-4C85-A956-631D5127A7A6 wds:Q74608100-AB042440-3958-4F7D-8990-5EA93452F41B
main subject	wd:Q423762 head and neck squamous cell carcinoma phase II clinical trial
PubMed ID	wds:Q74608100-2946C5F1-8F9D-487C-AE65-FC2D23117057
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/9610709
PubMed ID	9610709
published in	wds:Q74608100-52D3211B-8086-4875-925B-5103F211132D
published in	Cancer
issue	wds:Q74608100-CF64602C-CB79-4031-B8D8-EA364E98DF3F
volume	wds:Q74608100-E8B971D4-2F3C-4F53-A412-C7E7BC98264A
issue	11
volume	82
DOI	wds:Q74608100-C40A3A69-EA17-4890-BF2D-9131DA8F5075
DOI	http://dx.doi.org/10.1002/(SICI)1097-0142(19980601)82:11%3C2270::AID-CNCR24%3E3.0.CO;2-Q
DOI	10.1002/(SICI)1097-0142(19980601)82:11<2270::AID-CNCR24>3.0.CO;2-Q
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q74608100
is cites work of	Chemoradiation in Advanced Head and Neck Cancers: A Comparison of two Radiosensitizers, Paclitaxel and Cisplatin Cisplatin-Based Chemotherapy Options for Recurrent and/or Metastatic Squamous Cell Cancer of the Head and Neck A phase II evaluation of a 3-hour infusion of paclitaxel, cisplatin, and 5-fluorouracil in patients with advanced or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group study 0007. Outcome after re-irradiation of head and neck cancer patients. A prospective, randomized trial comparing neoadjuvant chemotherapy with radiotherapy alone in patients with advanced nasopharyngeal carcinoma Concurrent chemoradiation in the treatment of head and neck cancer Interstitial photodynamic therapy as salvage treatment for recurrent head and neck cancer Paclitaxel targets VEGF-mediated angiogenesis in ovarian cancer treatment Cisplatin, tegafur, and leucovorin: a moderately effective and minimally toxic outpatient neoadjuvant chemotherapy for locally advanced squamous cell carcinoma of the head and neck Chemotherapy in the management of squamous-cell carcinoma of the head and neck Combination chemotherapy and radiation of human squamous cell carcinoma of the head and neck augments CTL-mediated lysis. Phase II study of capecitabine as palliative treatment for patients with recurrent and metastatic squamous head and neck cancer after previous platinum-based treatment Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck Phase II study of paclitaxel, ifosfamide, and carboplatin in patients with recurrent or metastatic head and neck squamous cell carcinoma Zalutumumab plus best supportive care versus best supportive care alone in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck after failure of platinum-based chemotherapy: an open-label, randomised phase 3 trial Synergistic interactions between aminoflavone, paclitaxel and camptothecin in human breast cancer cells Phase I study of cisplatin analogue nedaplatin (254-S) and paclitaxel in patients with unresectable squamous cell carcinoma Ifosfamide, cisplatin, and 13-Cis retinoic acid for patients with advanced or recurrent squamous cell carcinoma of the head and neck: a phase I-II study Paclitaxel and gemcitabine in advanced non-nasopharyngeal head and neck cancer: a phase II study conducted by the Hellenic Cooperative Oncology Group Potential for efficacy of the oncolytic Herpes simplex virus 1716 in patients with oral squamous cell carcinoma Current treatment options for metastatic head and neck cancer Mutation of the class I beta-tubulin gene does not predict response to paclitaxel for breast cancer. Potential biomarkers for paclitaxel sensitivity in hypopharynx cancer cell A Phase II study of docetaxel and carboplatin as neoadjuvant therapy for nasopharyngeal carcinoma with early T status and advanced N status Induction chemotherapy for locoregionally advanced head and neck cancer: past, present, future? Randomized Phase II Study of Cabazitaxel Versus Methotrexate in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Previously Treated With Platinum-Based Therapy. Chemotherapy and immunotherapy for recurrent and metastatic head and neck cancer: a systematic review. Clinical benefit of nanoparticle albumin-bound-paclitaxel in recurrent/metastatic head and neck squamous cell carcinoma resistant to cremophor-based paclitaxel or docetaxel. Recurrent squamous-cell carcinoma of the head and neck: overview of current therapy and future prospects Epidermal growth factor receptor-targeted therapy potentiates lovastatin-induced apoptosis in head and neck squamous cell carcinoma cells Differential activity of caspase-3 regulates susceptibility of lung and breast tumor cell lines to Paclitaxel Organ preservation trials for laryngeal cancer Re-irradiation combined with capecitabine in locally recurrent squamous cell carcinoma of the head and neck. A prospective phase II trial A phase II trial of palliative docetaxel plus 5-fluorouracil for squamous-cell cancer of the head and neck A phase II trial of cisplatin and vinorelbine in patients with recurrent or metastatic squamous cell carcinoma of the head and neck Reirradiation for second primary or recurrent cancers of the head and neck: Dosimetric and outcome analysis A phase I study of a fixed dose of cisplatin with increasing doses of raltitrexed (Tomudex) in the treatment of patients with locally advanced or metastatic squamous cell carcinoma of the head and neck Induction paclitaxel in previously untreated, resectable, advanced squamous cell carcinomas of head and neck Phase I study of weekly nab-paclitaxel + weekly cetuximab + intensity-modulated radiation therapy (IMRT) in patients with stage III-IVB head and neck squamous cell carcinoma (HNSCC). A new high-performance liquid chromatography-tandem mass spectrometry method for the determination of paclitaxel and 6α-hydroxy-paclitaxel in human plasma: Development, validation and application in a clinical pharmacokinetic study. Use of high-dose cytarabine to enhance cisplatin cytotoxicity-effects on the response and overall survival rates of advanced head and neck cancer patients Phase II trial of biweekly gemcitabine and paclitaxel with recurrent or metastatic squamous cell carcinoma of the head and neck: Southwest Oncology Group study S0329. The role of chemotherapy for skull base carcinomas and sarcomas. Update on role of chemotherapy in head and neck squamous cell cancer Case report: Down-staging locally advanced head and neck cancer in an HIV infected patient in a limited resource setting Feasibility of reirradiation of recurrent sinonasal carcinoma in the periorbital region using hypofractionated image-guided intensity-modulated radiation therapy Phase I study of weekly docetaxel and cisplatin arterial infusion for recurrent head and neck cancer The current value of induction chemotherapy. ASCO Congress 2010
is cites work of	wds:Q35113123-2B1716EC-04E4-41CA-807B-948E5BBD224E

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software